Meghna Deshraj

In this episode, Sarah Bellenger, nurse veteran and entrepreneur, shares her journey creating Manage You, an app designed to fix inefficiencies in healthcare credentialing. She discusses the challenges of launching tech in a traditional industry, overcoming skepticism, and the importance of innovation and female leadership in healthcare. Sarah also reflects on funding disparities for women entrepreneurs and her vision for Manage You’s future impact on the industry.Chapters00:00 Introduction to Sarah Bellenger and Manage You03:07 The Need for Credentialing Solutions05:53 The Development Journey of Manage You08:48 Challenges in Healthcare Credentialing12:06 The App's Features and User Experience14:58 Expanding Manage You's Reach18:03 Future Developments and Scalability20:58 Entrepreneurial Insights and Challenges23:51 The Role of Women in Entrepreneurship26:47 Vision for the Future of Credentialing30:00 Conclusion and Call to ActionGuest Information:Guest's Name: Sarah BellengerGuest's Title/Position: Founder & Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/sarahrbellenger/Company / Affiliation: Manage You App https://www.manageyouapp.com/Guest's Bio: Sarah Bellenger is a clinician, Army veteran, and healthcare leader with over two decades of experience in patient care, team leadership, and system-wide operations. Her career spans cardiac ICU nursing, managing anesthesia teams across the U.S. and abroad, and even supporting executive health at the White House. After earning her MBA and serving in multiple leadership roles, Sarah recognized a recurring problem: capable professionals were burning out—not from the work itself, but from the inefficiencies surrounding it.Driven by her own experiences, including losing critical credentials during frequent relocations, Sarah founded Manage You—a mobile app that helps healthcare professionals and teams centralize documents, track deadlines, and simplify renewals. Her mission is clear: to reduce administrative burdens so clinicians can focus on what matters most—caring for patients.Takeaways:Sarah Bellenger is a nurse veteran and entrepreneur.Manage You addresses the inefficiencies in the credentialing process.Credentialing is a $39 billion industry with significant waste.The app allows users to store and manage their credentials efficiently.Users receive reminders for expiring documents directly on their phones.The app is designed to be user-friendly and secure.Sarah emphasizes the importance of networking and mentorship in entrepreneurship.Women face unique challenges in securing venture capital funding.The future of credentialing may involve digital verification and AI.Sarah is committed to making healthcare credentialing more efficient.

In this episode of The Healthy Enterprise, host Heath talks with Erin Morrow, Director of Product Management at Embark Veterinary, about how genetics and AI are transforming pet health. Erin shares her journey into product management, the role of dog DNA in better care decisions, and the challenges of building products in a fast-moving startup. She also dives into the integration of AI at work, the power of customer feedback, and creative marketing strategies—including collaborations with Disney. The conversation wraps with advice for aspiring professionals and a look at the future of technology in pet care.Chapters:00:00 Introduction to Embark Veterinary and Its Mission03:04 Erin Morrow's Journey and Background05:57 Understanding Dog DNA and Its Impact on Care09:03 The Role of Technology in Pet Care12:00 Future Innovations in Pet Health and AI14:59 Challenges in Product Development and Strategy17:55 The Value of Fractional Leadership20:49 Customer Feedback and Engagement Strategies26:49 Embracing AI in the Workplace30:12 Navigating Marketing Strategies38:41 Innovative Collaborations in Pet Care43:50 Advice for Aspiring ProfessionalsGuest Information:Guest's Name: Erin Morrow Guest's Title/Position: Director of Product ManagementGuest's Linkedin: https://www.linkedin.com/in/erin-morrow-68336829/Company / Affiliation: Embark Veterinary https://embarkvet.com/Guest's Bio: Erin Morrow is the Director of Product at Embark Veterinary, where she combines her passion for animals with cutting-edge technology to revolutionize pet care. With over 15 years of experience, she specializes in taking innovative products from initial concept through commercialization across SaaS, biotech, and educational technology sectors. Erin has a proven track record of building high-performing teams that consistently deliver products that users genuinely love. Her unique background includes a Bachelor's in Animal Science and Master's in Conservation Biology, giving her both the scientific rigor and deep empathy for animals and their caretakers that drives her customer-focused approach to product development.Takeaways:Embark Veterinary focuses on using genetics to enhance dog health.Erin Morrow has a diverse background in product management and animal science.Understanding a dog's DNA can significantly impact care decisions.The company has tested over 2 million dogs worldwide.AI and genomics are key to future pet health innovations.Customer feedback is crucial for product development.Fractional leadership can provide valuable insights and direction.Engaging with customers through social media enhances feedback.The importance of transitioning to a product-led organization.Continuous improvement in product offerings is essential for growth. We're starting to use AI internally and for customer-facing features.If you're writing an email, use ChatGPT for assistance.You still need to check your work; you are the subject matter expert.Finding the right tools is complex; experiment with different options.Word of mouth is still our strongest marketing engine.We collaborated with Colossus for our commercials.Our partnership with Disney was a significant campaign.We track brand awareness through customer feedback.Collaborations in the pet care space are yielding positive results.Follow your passion, but stay open-minded in your career. 

In this episode, Dr. Harsha Rajasimha discusses his journey as a biotech entrepreneur and the founder of Jeeva Clinical Trials. He shares insights into the inefficiencies of traditional clinical trials and how AI can streamline the process, making it more efficient and accessible. The conversation also touches on the importance of inclusivity in clinical research, the role of AI agents, and the personal motivations behind his work. Dr. Rajasimha emphasizes the need for a unified platform to enhance collaboration and reduce complexity in clinical trials, ultimately aiming to improve patient outcomes.Chapters:00:00 Introduction to Jiva Clinical Trials and Harsha Rajaseema02:50 The Clinical Trial Process: Challenges and Innovations05:51 AI in Clinical Trials: Enhancing Efficiency and Security08:59 The Role of AI Agents in Clinical Research11:55 Addressing Inequities in Clinical Trials15:02 Philanthropy and Patient Advocacy in Rare Diseases18:08 The Journey of an Entrepreneur: Insights and AdviceGuest Information:Guest's Name: Dr. Harsha K. RajasimhaGuest's Title/Position: Founder & Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/harsharajasimha/Company / Affiliation: Jeeva Clinical Trials https://jeevatrials.com/Guest's Bio: Dr. Harsha K. Rajasimha is a scientist, entrepreneur, and patient advocate, and the Founder & CEO of Jeeva Clinical Trials—an AI-driven platform making clinical research more efficient and accessible worldwide. He also serves as Founder and Chair of the Indo US Organization for Rare Diseases, building global collaboration to improve outcomes for patients with rare conditions. Motivated by personal loss, Harsha has dedicated his 20-year career in precision medicine and biotech to advancing rare disease research, patient advocacy, and the use of technology to accelerate clinical trials.Takeaways:Dr. Harsha Rajasimha is the founder of Jeeva Clinical Trials.Clinical trials typically take 8-10 years to complete.AI can significantly reduce the time and cost of clinical trials.The current clinical trial infrastructure is complex and fragmented.Jeeva aims to unify the clinical trial process with a single platform.AI agents will automate repetitive tasks in clinical trials.Inclusivity in clinical trials is crucial for diverse patient representation.Philanthropy plays a key role in Dr. Rajasimha's mission.The platform supports over 100 languages for global accessibility.Community support is essential for entrepreneurial success.

In this episode, Bill Wittmeyer discusses his journey as the CEO of Maggie's Breath, a company focused on using breath analysis for early detection of breast cancer. He shares insights into the technology behind breath analysis, the importance of early detection, and the challenges faced in the healthcare industry. Bill also reflects on the personal impact of breast cancer in his life and the future plans for Maggie's Breath, including clinical trials and funding efforts.Chapters:00:00 Introduction to Bill Wittmeyer and Maggie's Breath03:04 The Journey to Breath Analysis Technology05:55 The Importance of Early Detection in Breast Cancer08:56 Innovative Screening Methods and Their Implications11:49 The Role of Metabolic Compounds in Disease Detection15:05 Challenges in Implementing New Screening Technologies18:01 Mobile Screening Solutions for Breast Cancer20:59 Future Directions and Global Health Implications26:55 Clinical Trials and Market Opportunities30:02 Innovative Screening Technologies34:04 Navigating Regulatory Challenges36:10 The Journey of a Startup Founder41:45 Personal Loss and Legacy49:30 Fundraising and Community EngagementGuest Information:Guest's Name: Bill WittmeyerGuest's Title/Position: Founder & Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/bill-wittmeyer-b0628a/Company / Affiliation: Maggie's Breath https://www.maggiesbreath.com/ Guest's Bio: Bill Wittmeyer is the Founder and CEO of Maggie’s Breath (formerly Pulmostics Limited) where he applies advanced detection technologies—such as high-speed gas chromatography—to protect human health and the environment. Maggie’s Breath was renamed in honour of Bill’s late wife, Maggie, who lost her battle with breast cancer while working to advance life-saving diagnostics. Her vision lives on through the company’s mission: to create a revolutionary, non-invasive breath-based screening tool that can detect disease early and save lives. Bill’s leadership spans innovations in healthcare, environmental monitoring, and public safety, all driven by a commitment to turning personal loss into global impact for a healthier, more sustainable world.Takeaways:-Bill Wittmeyer is the CEO of Maggie's Breath, focused on breath analysis for breast cancer detection.-Maggie's Breath aims to provide a non-invasive screening tool for breast cancer.-The technology can analyze breath samples in just one minute.-Breast cancer is increasingly affecting younger women, necessitating early detection methods.-Current mammogram practices may not be effective for women with dense breast tissue.-Breath analysis could complement existing mammogram technologies.-The goal is to provide diagnostically actionable information at the point of care.-Maggie's Breath was named in honor of Bill's late wife, who passed away from breast cancer.-The company is seeking funding and partnerships to conduct clinical trials in Mexico.-Bill emphasizes the importance of early detection in improving survival rates and reducing treatment costs. 

In this episode, Dr. Steve Schutzer shares his journey from a Bronx kid to a prominent orthopedic surgeon and co-founder of Upswing Health. He discusses the importance of improving patient experiences in healthcare, the challenges faced in the industry, and the innovative solutions Upswing Health offers to streamline orthopedic care. The conversation highlights the significance of direct primary care, functional medicine, and the need for interoperability in healthcare systems. Dr. Schutzer emphasizes the entrepreneurial spirit required to address healthcare challenges and the importance of mentorship and effective communication in achieving success.Chapters:00:00 Introduction to Dr. Steve Schutzer and Upswing Health02:49 Dr. Schutzer's Journey in Medicine06:02 Mentorship and the Impact of Innovation in Orthopedics08:51 Creating Centers of Excellence in Joint Replacement11:55 Challenges in Healthcare and the Role of Legislation14:50 Direct Pay and Direct Primary Care Innovations18:01 Functional Medicine and Preventative Healthcare21:06 The Future of Healthcare and Entrepreneurial Medicine31:39 The Shift to Entrepreneurship32:25 Building Centers of Excellence34:48 Identifying the Ouch Moment36:12 Innovative Solutions in Orthopedics39:11 The Evolution of Orthopedic Management41:28 The Vision for Upswing44:20 Navigating Healthcare Challenges47:30 Interoperability in Healthcare51:27 The Future of Upswing55:45 The Role of Employers in Healthcare58:42 Marketing Strategies for UpswingGuest Information:Guest's Name: Steve Schutzer Guest's Title/Position: Co-Founder and Chief Medical Officer Guest's Linkedin: https://www.linkedin.com/in/steve-schutzer-md-81616125/Company / Affiliation: Upswing Health https://upswinghealth.com/Guest's Bio: Steve Schutzer is an orthopedic surgeon specializing in adult hip and knee reconstruction, with decades of experience leading joint replacement programs and advancing value-based orthopedic care. He believes in the power of connected communities and digital technologies—especially in today’s accelerating AI environment—working alongside compassionate human caregivers to solve complex medical challenges. Recognized as a focused, innovative, and visionary healthcare physician leader and strategist, Steve has an enduring obsession with improving the patient experience.Takeaways:Dr. Schutzer's journey reflects the unpredictability of career paths.The importance of mentorship in shaping a physician's career.Building centers of excellence can significantly improve patient care.Healthcare challenges are often rooted in financial disincentives.Direct primary care offers a promising alternative to traditional models.Functional medicine focuses on prevention and holistic care.Upswing Health aims to provide quick access to orthopedic care.Interoperability in healthcare is crucial for better patient outcomes.The rise of early onset cancers highlights the need for preventive care.Entrepreneurship in healthcare requires resilience and adaptability.

In this episode of The Healthy Enterprise, Jessicca Rege shares her groundbreaking work in cancer research at Sus Clinicals, where her team uses genetically modified “Oncopigs” to bridge the gap between preclinical and clinical trials. She discusses her path from academia to industry, her dual role as Chief Medical Officer at OncoScope AI, and her commitment to pushing the boundaries of oncology through innovative research, AI integration, and precision medicine. Jessicca also opens up about overcoming imposter syndrome, navigating the challenges of being a female leader, and mentoring the next generation of women in science. The conversation explores Sus Clinicals’ growth strategies in large animal research and offers inspiring insights for aspiring leaders on resilience, vision, and questioning the status quo.Chapters:00:00 Introduction to Jessicca Rege and Sus Clinicals07:30 The Oncopig Model: Revolutionizing Cancer Research18:04 The Journey of a Mutant Pig Farmer24:51 AI in Cancer Research and Future Directions27:14 Introduction to OncoScope AI and Leadership Roles28:36 Disruptive Leadership and Questioning the Status Quo30:45 Navigating Imposter Syndrome as a CEO32:42 The Challenges of Being a Female Leader35:41 Cultivating Future Female Leaders39:03 Steering Growth at Sus Clinicals41:33 Innovative Approaches in Large Animal Research45:34 Future Outlook and Goals for Sus Clinicals49:25 Advice for Aspiring LeadersGuest Information:Guest's Name: Jessicca RegeGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/jessiccarege/Company / Affiliation: Sus Clinicals https://susclinicals.com/Guest's Bio: Jessicca Rege is a pharmaceutical executive with extensive experience in oncology drug development, from pre-IND through commercialization. She has led R&D, regulatory, and medical affairs teams in both large pharma and biotech, guided in-licensing and acquisition strategies, and worked closely with global regulatory authorities. Jessica is also a trusted voice with investors, scientific leaders, and industry partners, advancing innovative cancer therapies worldwide.Takeaways:Jessicca Rege is passionate about transformative research in cancer.Sus Clinicals uses genetically modified pigs to advance cancer research.The Oncopig model allows for testing efficacy, safety, and metabolic effects.Cancer patients are often more knowledgeable about their conditions than expected.Jessica emphasizes the importance of empathy in patient care.The Oncopig model can replicate human cancers on demand.Precision medicine is becoming the standard in oncology.AI is being utilized in cancer research for systematic literature reviews.Jessica's journey reflects a commitment to improving patient outcomes.The integration of various medical professionals is crucial in cancer treatment. I am known as a disruptive leader.Imposter syndrome is always going to be with us.We want to continue to build models that enable researchers.We have a hundred percent success rate in being able to induce tumors.We believe the uptake is coming in.We could sell each of our different models to a different CRO.We hope to become a profitable company by 2027.You get more nos than you get yeses.I love the impact that I'm making on the teams.

In this episode, Braden Pan, CEO and founder of Resolve, discusses the significant issue of medical debt in America, which affects one in three individuals and is a leading cause of bankruptcy. He shares his personal journey that led him to create Resolve, a company dedicated to helping patients navigate and reduce their medical bills. Braden elaborates on the challenges of founding a startup, the integration of AI in their processes, and the importance of negotiating with hospitals. He also emphasizes the need for co-founders and the evolution of his leadership style as the company grows. The conversation highlights the future of Resolve, focusing on B2B expansion and the broader goal of addressing various types of debt.Chapters:00:00 Introduction to Resolve and Medical Debt03:11 Braden's Personal Journey and Founding Resolve06:11 Navigating the Complexities of Medical Billing09:05 The Role of AI in Medical Billing Solutions12:05 Understanding Hospital Billing Practices14:47 The Impact of Medical Debt on Patients17:58 Marketing Strategies and Patient Success Stories20:53 Future Directions for Resolve22:37 Navigating Financial Aid in Healthcare25:22 The Role of a Founder and CEO30:40 Shifting Business Strategies and Messaging32:14 Future Aspirations and Goals35:25 Leadership Evolution and Team Dynamics39:34 Advice for Aspiring Founders and Co-foundersGuest Information:Guest's Name: Braden PanGuest's Title/Position: CEO and FounderGuest's Linkedin: https://www.linkedin.com/in/bradenpan/Company / Affiliation: Resolve https://www.resolvemedicalbills.com/Guest's Bio: The idea for Resolve was sparked in 2016, when founder Braden Pan received an outrageous hospital bill for a brief, 15-minute consultation. Frustrated by the complex and opaque billing process, Braden set out to find a better way. That experience became the foundation for Resolve—a company dedicated to helping Americans fight back against unfair medical bills. Since then, Resolve has tackled all types of healthcare billing challenges, partnering with experts across the healthcare ecosystem to reduce financial stress and bring greater transparency to the system.Takeaways:Medical debt is a massive issue affecting many Americans.Resolve has saved patients over $55 million on medical bills.Braden's personal experience with medical debt inspired him to start Resolve.The healthcare system is complex and often designed to confuse patients.AI is being integrated into Resolve's processes to improve efficiency.Hospitals often prefer working with Resolve to lower their collection costs.Financial aid programs exist but are underutilized by patients.Braden emphasizes the importance of having a co-founder.Leadership evolves over time, especially in a startup environment.The future of Resolve includes expanding services to address all types of debt.

In this episode we will meet with Stephanie Dorwart, CEO of Altius Healthcare Consulting Group, for a wide-ranging conversation about how healthcare is changing—and what leaders need to do to keep up. We talk about the long-term impact of COVID-19, the growing role of data in driving smarter operations, and why strong, accountable leadership matters more than ever. Stephanie also shares her own journey from math teacher to healthcare CEO, and offers insights on the future of the industry—from the rise of telehealth to the unique challenges facing rural health systems.Chapters:00:00 Introduction to Altius Healthcare Consulting02:46 Stephanie's Journey into Healthcare06:50 Impact of COVID-19 on Healthcare Innovation10:32 The Role of Data in Healthcare12:02 Empowering Leaders through Data14:28 Building Trust and Accountability in Leadership18:13 The Importance of Continuous Improvement in Healthcare22:31 Navigating Leadership Development30:12 The Entrepreneurial Leap37:59 Innovations in Healthcare41:14 Vision for the Future of AltiusGuest Information:Guest's Name: Stephanie DorwartGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/stephanie-dorwart/ Company/Affiliation: Altius Healthcare Consulting Group https://altiushcg.com/Guest's Bio: Stephanie Dorwart is the CEO of ALTIUS, a healthcare consulting firm she rebranded and now leads with a hands-on, results-driven approach. With over 15 years of experience in performance improvement and labor management, she’s worked with hospitals of all sizes—from rural facilities to large academic medical centers—helping them improve financial performance, patient outcomes, and staff satisfaction. Known for her analytical expertise and deep industry insight, Stephanie consistently delivers measurable ROI and lasting client impact. Takeaways:Altius focuses on improving financial and operational performance in healthcare.Stephanie transitioned from teaching to healthcare due to a passion for data and patient care.COVID-19 accelerated the adoption of telehealth and innovative care models.Data in healthcare is relatively new and can significantly impact productivity.Empowering leaders with data helps them make informed decisions.Building trust within teams is essential for effective leadership.Accountability starts with setting clear goals and regular check-ins.Time management is crucial for leaders to think strategically.Rural healthcare systems face unique challenges and need support.The future of healthcare may focus more on preventive care and nutrition.

In this episode of The Healthy Enterprise as we dive into the world of sustainable innovation with Yuliana Mihaylova, a biotech executive and co-founder of OliveBio. Discover how Yuliana's journey from a PhD in genetics to an entrepreneur is paving the way for eco-friendly alternatives to petrochemical plastics. Learn about the challenges and triumphs of creating scalable bioplastics and the role of AI in revolutionizing production processes.Chapters:00:14 Introduction to OliveBio and Yuliana's Background02:01 The Motivation Behind OliveBio: Tackling Plastic Pollution06:15 Understanding PHAs: A Sustainable Bioplastic Solution11:59 OliveBio's Innovative Production Process for PHAs15:57 Applications and Future of Bioplastics18:21 Yuliana's Entrepreneurial Journey and Challenges22:36 Leveraging AI and Automation in Biotech33:13 Marketing and Growth Strategy for OliveBio36:49 Vision for OliveBio's Future Impact39:43 Key Learnings and Advice for Aspiring InnovatorsGuest Information:Guest's Name: Yuliana MihaylovaGuest's Title/Position: CEO & Co-FounderGuest's Linkedin: https://www.linkedin.com/in/yulianamihaylova/Company / Affiliation: OliveBio https://olivebio.com/Guest's Bio: Yuliana Mihaylova is a seasoned biotech executive and the team’s mission enforcer. After completing her Genetics PhD and post-doctoral research at the universities of Nottingham and Oxford, respectively, she worked in biotech and pharma management consulting, where she helped companies develop their asset commercialization and market access strategies. From 2019 to 2024, Yuliana was part of the executive team at Basepaws, a pet genetics company, acquired by the animal pharma startup Zoetis in 2022. As Basepaws’ Head of R&D, she led the development and refinement of new technologies and scientific products and was a key stakeholder in the translation of scientific discovery into business strategy.Yuliana believes strongly in the power of cross-disciplinary collaboration and innovative thinking to solve the world’s most pressing environmental challenges.Takeaways:OliveBio, co-founded by Yuliana Mihaylova, is developing scalable, affordable bioplastics to combat plastic pollutionFocuses on PHAs, biodegradable polymers from renewable sources that leave no microplasticsUses enzyme-based production instead of bacterial fermentation for better precision and lower costsPHAs have broad applications: packaging, single-use items, agriculture, 3D printing, and medical uses like suturesYuliana’s entrepreneurial journey includes adapting quickly, embracing failure, and bootstrapping with limited resourcesAI is integrated into OliveBio’s production systems and daily operations to enhance efficiency and accuracyMarketing strategy targets B2B2C—engaging businesses and influencing consumer demandLong-term vision is to build a sustainable, impactful company rather than seeking early acquisition

In this episode of the Healthy Enterprise podcast, David Georges, North American president of Koning Health, discusses his extensive experience in the breast imaging industry and the innovative BreastCT technology. He shares insights into the challenges of traditional mammography, the importance of early detection, and the potential of BreastCT to revolutionize breast cancer screening. The conversation also touches on the integration of AI, the global market expansion of the technology, and the significance of mentorship and leadership in driving change within healthcare.Chapters:00:00 Introduction to Breast Imaging Innovations02:49 David Georges' Journey in Breast Cancer Detection06:02 The Evolution of Breast Imaging Technology08:54 Challenges in Mammography and Patient Compliance11:58 Commercialization of BreastCT Technology14:46 Navigating Change in Medical Imaging18:11 Global Expansion and Future Vision for Koning Health20:45 The Impact of BreastCT on Patient Experience23:51 Addressing Resistance and Building Trust in New Technology26:58 The Future of Breast Imaging and Biopsy Procedures30:33 Understanding the Breast Imaging Industry32:28 The Role of AI in Breast Imaging34:04 Creating Commercial Viability for New Technology36:30 Educating Radiologists on New Imaging Techniques39:18 Building Confidence in Radiologists42:10 Transitioning to New Technologies in Imaging44:57 Career Guidance in Healthcare and Technology49:42 Mobile Breast Imaging Solutions54:08 The Economic Impact of Early Detection56:34 Future Prospects for Breast Imaging TechnologyGuest Information:Guest's Name: David GeorgesGuest's Title/Position: North American PresidentGuest's Linkedin: https://www.linkedin.com/in/david-georges-48a14020/Company / Affiliation: Koning Health https://www.koninghealth.com/Guest's Bio: David Georges has been a global business leader in Breast Imaging for the past twenty-five years, contributing to the introduction and substantial market growth of innovative products dedicated to the early detection of breast cancer including mammography, breast biopsy, computer aided detection, breast ultrasound and automated breast ultrasound. David has established manufacturing sites, supported luminary sites for new product introduction, and established physician and technologist training centers. He has held senior executive positions in companies such as Transworld, Lorad, Hologic, R2, SuperSonic Imagine, iVu and U-systems; the latter of which was purchased by GE.Since joining Koning, David has led the effort to move the company from a Research and Development group to one that is prepared for commercializing Koning’s KBCT. David’s industry relationships have introduced opportunities to establish critically important luminary partners. With a knowledge of global distribution, David has expanded the Koning installation base to Thailand, Qatar, and Netherlands.Takeaways:David Georges has 40 years of experience in breast imaging.BreastCT technology offers true isotropic 3D imaging without compression.Early detection of breast cancer significantly improves treatment outcomes.Patient compliance with mammograms is low due to discomfort.Koning Health aims to integrate BreastCT into existing facilities easily.The technology is gaining traction in global markets, including China and Australia.AI will play a crucial role in interpreting BreastCT images.Mobile BreastCT units are being deployed to increase accessibility.Healthcare economics favor early detection to reduce treatment costs.

In this episode, Eitan Akirav shares his journey from academia to the biotech industry, discussing the importance of mentorship, innovations in diabetes research, and the role of AI in healthcare. He emphasizes the need for a holistic approach to biomarkers and the future of oncology treatments. Eitan also provides insights into the challenges of consulting and the importance of building strong client relationships.Chapters:00:00 Introduction to Eitan Akirav and His Journey03:13 Transitioning from Academia to Industry06:03 The Role of Mentorship in Career Development09:04 Leadership in Academia vs. Industry11:58 Innovations in Diabetes Research and Patents15:02 The Future of Diabetes Detection and Prevention17:56 The Impact of AI in Healthcare21:03 Disruptive Innovations in Life Sciences25:31 The Concept of Cure in Cancer Treatment28:09 Balancing Technology and Human Touch in Healthcare29:52 The Economic Challenges of Drug Development32:50 Advice for Newcomers in the Science Industry36:46 Challenges in Consulting and Marketing Yourself44:44 Final Thoughts and Reflections on the JourneyGuest Information:Guest's Name: Eitan Akirav Guest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/eitan-akirav/Company/Affiliation: KonKai Ventures https://www.linkedin.com/company/konkai-consulting/posts/?feedView=allGuest's Bio: Eitan Akirav is a seasoned biotech leader with over 17 years of experience bridging scientific innovation and business strategy. From leading global biomarker programs at Cerba Research to launching rapid COVID-19 diagnostics at Enzo, he’s driven impactful solutions across the biotech and healthcare landscape. Earlier in his career at NYU, he secured multimillion-dollar research funding and led clinical trials in autoimmunity. With work featured in PNAS and Nature Immunology, Eitan continues to advance science at the intersection of research, innovation, and real-world application.Takeaways:Eitan Akirav has over 17 years of experience in biotech.Mentorship plays a crucial role in career transitions.The transition from academia to industry can be challenging but rewarding.Innovations in diabetes research are focused on early detection.AI is a powerful tool that can save time in healthcare.The future of oncology may involve re-engineering immune cells.Customized medications based on genetic information are on the rise.The drug approval process is lengthy and complex.Newcomers in biotech should pursue their passion, not just titles.Consulting requires effective self-marketing and client relationship management.

In this episode of The Healthy Enterprise, Dr. Josh Funk, CEO of Rehab to Perform, shares his journey from college athlete to the head of a thriving, multi-location physical therapy practice. He dives into what it takes to build a business rooted in performance, culture, and innovation—especially in the evolving healthcare space. Dr. Funk discusses strategies for leadership, employee retention, and navigating growth while staying true to core values. From adapting during the COVID-19 pandemic to embracing AI and automation, Dr. Funk emphasizes the need for transparency, adaptability, and a relentless focus on patient empowerment to stay ahead in the industry.Chapters:00:00 Introduction to Dr. Josh Funk and Rehab 2 Perform01:07 Dr. Funk's Journey: From Athlete to Entrepreneur03:48 Growth of Rehab 2 Perform: From One to Eleven Locations06:38 Leadership and Culture: Infusing Vision Across Locations12:20 Retention Strategies: Keeping the Right Talent17:07 Challenges and Learning: Navigating Business Growth20:20 Adapting to COVID-19: Innovations and Changes24:01 Balancing Process and Human Connection27:10 Innovative Service Delivery in Physical Therapy30:03 The Role of Patient Participation in Recovery35:13 Growth Strategies for Rehab 2 Perform38:07 Navigating Marketing in a Competitive Landscape40:43 Challenges in the Healthcare System43:12 Leveraging AI for Efficiency48:40 Envisioning a Better Healthcare SystemGuest Information:Guest's Name: Dr. Josh FunkGuest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/joshfunk/Company / Affiliation: Rehab 2 Perform https://rehab2perform.com/Guest's Bio: Dr. Josh Funk is the Founder and CEO of Rehab 2 Perform (R2P), a growing performance-based physical therapy company redefining how people experience rehab and recovery. With a model rooted at the intersection of movement, mindset, and long-term performance, Dr. Funk and his team focus on helping clients—from athletes and new moms to first responders and everyday movers—level up, not just heal.Under his leadership, R2P has grown into a multi-location, multi-state business that blends clinical excellence with a community-driven culture. The core philosophy? Treat people like athletes, build a better baseline, and help them perform for life.Dr. Funk also co-leads R2P Academy, an education and mentorship platform for clinicians, intrapreneurs, and future leaders in performance healthcare. A frequent speaker on topics like growth strategy, identity-based care, and scaling with soul, Dr. Funk is passionate about building businesses that make a lasting impact—inside and outside the clinic.Takeaways:Dr. Funk’s background as an athlete shapes his leadership style.Strong company culture is essential for multi-location success.Retention strategies are key when working with a young team.The pandemic accelerated innovation and adaptation.Balancing systems with human connection is critical in healthcare.Patient empowerment leads to better recovery and long-term results.Focusing on movement and performance—not just pain—is core to R2P’s approach.AI and automation can improve operations without replacing people.Transparent leadership builds alignment and trust.R2P plans to continue expanding its reach and impact.

In this conversation, Ed Fleischer shares his extensive career journey in the biotech industry, detailing his experiences from working in large pharmaceutical companies to transitioning into consultancy. He discusses the importance of staying current with industry trends, the impact of AI on biotech, and innovations in quality control. Edwin reflects on meaningful experiences that shaped his career, the significance of leadership and communication, and the motivation behind delivering life-changing medicines to patients.Chapters:0:00 - Introduction to Ed Fleischer2:09 - From Biotechnology to Consultancy10:00 - The Journey Through Major Pharma13:00 - Staying Current in a Dynamic Field14:43 - The Impact of AI on QC21:06 - The "Why" Behind the Work32:20 - Leadership and Authenticity36:51 - The Value of Public Speaking42:42 - Delivering on Trust46:11 - Conclusion and TakeawaysGuest Information:Guest's Name:  Ed FleischerGuest's Title/Position: Chief Executive Officer Guest's Linkedin: https://www.linkedin.com/in/ed-fleischer-a780482/Company/Affiliation: Beachside Compliance SolutionsGuest's Bio: Ed Fleischer is a seasoned Quality Control executive with a strong track record of leading quality improvement, operational excellence, and compliance initiatives in the biotechnology industry. With deep expertise in biotechnology processes, quality systems, and regulatory requirements across both domestic and international markets, he has successfully collaborated with agencies such as the FDA, EMA, and others. Ed is also the CEO of Beachside Compliance Solutions, a consultancy specializing in analytical and Quality Control challenges, where he offers independent, expert guidance to organizations navigating complex regulatory environments. He is passionate about developing talent and fostering a culture of quality at all levels of an organization.Takeaways:-He transitioned to consultancy after working in various pharmaceutical companies.-Staying current with regulations and industry trends is crucial for success.-AI is becoming increasingly important in the biotech field.-Innovations in quality control are revolutionizing the industry.-Ed's impactful experience with a patient highlighted the importance of their work.-Leadership requires authenticity and the ability to communicate effectively.-Diversity in teams leads to better problem-solving and innovation.-Consultants care about the outcomes of their work and follow up with clients.-The pharmaceutical industry is driven by the need to deliver safe and effective medicines. 

In this conversation, Wendy Slone, PhD, discusses her journey as an entrepreneur and the development of her company, BTEC, which focuses on innovative wound care solutions through the Halcyon Smart Patch. She emphasizes the importance of healing from within, the challenges of entrepreneurship, and the significance of building relationships and networking. Wendy also shares her insights on empowerment, particularly for women in business, and the need for a strong support system.Chapters:00:13 Introducing Dr. Wendy Sloan & B-Tech01:13 The Halcyon Smart Patch: Healing from the Inside Out02:02 The Personal Spark Behind B-Tech03:32 From NASA to Public Policy: Dr. Sloan’s Journey06:26 Far Infrared Light, Explained07:58 The Chronic Wound Care Crisis10:00 The Hidden Burden of Chronic Wounds13:51 B-Tech’s Buzz & Upcoming Human Trials15:06 Real-World Potential: Animals, Space & Defense18:53 Growing B-Tech: Early Lessons & Challenges20:07 Why Strategy Matters More Than Just the Product27:26 Building Investor Trust & Strategic Partnerships33:04 Mentorship, Boldness & Breaking Barriers36:09 Owning the Room & Overcoming Imposter Syndrome41:18 Resilience, Community & Entrepreneurial Grit43:05 Final Reflections on a Remarkable JourneyGuest Information:Guest's Name: Dr Wendy Slone Guest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/wendy-s-ba02b240/Company / Affiliation: bTECH https://btechls.com/Guest's Bio: Dr. Wendy Slone is the founder and CEO of bTECH Inc., where she leads the development of the Halcyon SMART Patch—a wearable healing technology designed to revolutionize chronic wound care. Inspired by her mother’s experience with diabetic ulcers, Dr. Slone combines personal passion with deep scientific expertise. She holds a Ph.D. in public policy, is pursuing a second doctorate in chemistry, and brings over 15 years of experience in data analytics and entrepreneurship. Her mission is clear: to transform outcomes for patients facing chronic wounds through innovation, science, and purpose-driven leadership.Takeaways:BTEC's Halcyon Smart Patch focuses on healing wounds from the inside out.Microcirculation is crucial for effective wound healing.The wound care industry is often overlooked despite its significance.Entrepreneurship involves navigating various challenges and obstacles.Building a solid business model is essential for success.Networking and building relationships are key to finding investors.Women entrepreneurs often face unique challenges and need support.It's important to maintain a positive attitude and resilience in business.Asking questions and challenging the status quo is vital for growth.Creating a core support system can significantly impact an entrepreneur's journey.

In this episode, Aimee Taylor, Founder and CEO of Alt Digital Marketing, shares her journey from traditional television marketing to the digital landscape, emphasizing the importance of strategy, authenticity, and client engagement in marketing. She discusses the evolving role of AI and SEO, the significance of human connection in marketing, and the challenges faced in healthcare marketing. Aimee also provides valuable insights for aspiring marketers, highlighting the need for hiring the right talent and the importance of transparency with clients.Chapters:00:00 Introduction to Digital Marketing and Transition from Traditional Media05:02 The Importance of Strategy in Marketing09:53 Navigating the AI Landscape in Marketing15:02 Understanding SEO and Its Evolution19:59 The Role of Websites in Modern Marketing24:47 The Role of Human Operators in Marketing25:42 Authenticity and Credibility in the Digital Age27:05 Navigating Google Business Profiles28:54 The Importance of Local SEO and Reviews30:39 The Value of Human Connection in Marketing32:58 Understanding the Client's Journey34:54 The Impact of Call Tracking on Business36:23 Healthcare Marketing: A Shift in Consumer Behavior38:51 The Future of Preventative Healthcare40:25 Adapting to AI in Marketing42:07 Leadership and Team Dynamics in Marketing46:35 Advice for Aspiring MarketersGuest Information:Guest's Name:  Aimee TaylorGuest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/aimee-taylor/Company/Affiliation: Alt Digital Marketing https://altdigitalmarketing.com/Guest's Bio: Aimee Taylor is the Founder and CEO of Alt Digital Marketing, a company that specializes in medical marketing with particular emphasis on the aesthetics industry. Aimee has over 13 years of digital marketing experience, which is bolstered by two decades of broadcast TV sales. She has a deep understanding of all aspects of digital and traditional marketing. She has a BA in Telecommunications from Indiana University, Bloomington, IN.Takeaways:Digital marketing offers more trackable results compared to traditional media.Strategy is crucial in navigating the complex marketing landscape.Clients need to niche down to effectively market their services.AI is reshaping marketing, but human oversight remains essential.Authenticity and credibility are vital for successful marketing campaigns.The website serves as the foundation for all marketing efforts.Engagement with clients enhances the effectiveness of marketing strategies.Healthcare marketing is evolving towards a focus on wellness and preventative care.Effective leadership involves hiring the right people and fostering a positive team culture.

In this conversation, Mary Hames, CEO and founder of BioLogic Pharma Solutions, discusses her journey in the biotech and pharmaceutical consulting industry. She explains the fractional model of consulting, which allows smaller companies to access expertise without the financial burden of hiring full-time staff. Mary shares her entrepreneurial journey, the importance of company culture, and the challenges of consulting in a dynamic environment. She also highlights the significance of trust in startups and her aspirations for the future of her company.00:00 Introduction to BioLogic Pharma Solutions03:01 The Fractional Model in Biotech Consulting06:00 Navigating Uncertainty in Drug Development09:04 Mary's Entrepreneurial Journey11:50 Vision for the Future of Biotech Consulting14:45 Challenges in Consulting and Growth17:57 The Importance of Trust in Entrepreneurship26:49 The Importance of Delegation in Business28:02 Navigating Client Acquisition and Marketing Strategies30:35 Effective Client Engagement and Presentation Techniques34:12 Understanding Market Dynamics and Client Feedback36:11 Identifying the Sweet Spot in the Drug Development Process39:25 Building a Flexible Workforce and Consultant Relationships40:19 Future Aspirations and Growth Strategies for the Company46:12 Reflections on the Entrepreneurial JourneyGuest Information:Guest's Name: Mary Hames Guest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/mary-hames-phd-biologicpharmasolutions/Company / Affiliation: BioLogic Pharma Solutions https://biologicpharmasolutions.com/Guest's Bio: Mary Hames is a scientist-turned-strategic leader with over a decade of experience guiding biotech and pharma companies from breakthrough science to real-world impact. With deep expertise in neurology, rare diseases, and radiopharmaceuticals, Mary has held roles spanning R&D, medical affairs, diagnostics, and executive leadership. She specializes in translating complex science into strategic action—building scalable systems, aligning cross-functional teams, and accelerating development and launch readiness. Known for her clarity, energy, and execution, Mary thrives in high-stakes environments where innovation meets urgency. Takeaways:The fractional model allows companies to access expertise without full-time hires.Building a company culture is essential for employee satisfaction.Consulting can be lonely, but teamwork helps mitigate that.Marketing strategies include presentations and SEO efforts.Trust is crucial for entrepreneurs to delegate responsibilities.The future of BioLogic includes becoming a go-to firm for pre-commercial products.Navigating uncertainty in drug development is a common challenge.Mary's entrepreneurial journey includes learning from past failures.The sweet spot for consulting is between phase two and three of drug development.

In this episode, Dr. Paula Muto shares her journey as a surgeon and entrepreneur, discussing her experiences in the medical field and the founding of UberDoc, a platform designed to provide patients with direct access to healthcare professionals. She emphasizes the importance of leadership, teamwork, and the challenges faced by women in medicine. Dr. Muto also highlights the need for innovation in healthcare and how UberDoc aims to empower patients by simplifying access to medical care.00:00 Introduction to Dr. Paula Muto and Her Journey02:33 Building the Muto Vein Center: A Personal Journey04:26 Leadership in Healthcare: Building a Strong Team07:06 Challenges in Modern Medicine: The Human Element09:38 Gender Disparities in Surgery: A Personal Perspective12:01 The Evolution of Surgical Practices and Technology12:46 Introducing UberDoc: A Solution for Patient Access15:55 The UberDoc Model: Direct Access to Care20:23 Insurance and Flexibility: The Future of Healthcare22:24 Overcoming Resistance: The Journey of UberDoc26:09 Expanding the Network: The Growth of UberDoc28:16 Streamlining Patient Appointments31:18 The Evolution of Telemedicine34:59 Building the UberDoc Team38:17 Funding and Expansion Strategies40:52 The Future of Direct Pay Healthcare45:03 Reimagining Patient CareGuest Information:Guest's Name:  Paula MutoGuest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/paulamutomd/Company/Affiliation:  UBERDOC - https://uber-docs.com/Guest's Bio: UBERDOC Founder and CEO Paula M. Muto, MD FACS, is a practicing vascular and general surgeon in solo practice and the owner of Muto Vein Center. She is a member of a family of physicians and surgeons who have collectively practiced medicine in Massachusetts for over 50 years. She is an outspoken advocate for patient care and is passionate about women’s health issues. Takeaways:Dr. Muto comes from a long line of surgeons and is passionate about restoring healthcare.Leadership in healthcare requires understanding and flexibility with team dynamics.Women in medicine face unique challenges, including compensation disparities.The healthcare system often prioritizes billing over patient care, leading to inefficiencies.UberDoc was created to solve the problem of access to healthcare for patients.The UberDoc model allows patients to pay directly for appointments, bypassing insurance complexities.Building a strong team is crucial for the success of any healthcare venture.Direct pay models are gaining traction as a solution to healthcare access issues.The future of healthcare may involve more technology and patient empowerment.Dr. Muto encourages collaboration among healthcare professionals to improve patient outcomes.

In this episode, Heath Fletcher and Kevin Scanlon delve into the intricacies of entrepreneurship, investment, and the vital role of character and team dynamics in achieving success. They discuss the importance of mentorship, the challenges entrepreneurs face in communicating with investors, and the significance of trust in business relationships. Kevin shares insights from his extensive experience in angel investing and teaching entrepreneurship, highlighting the need for adaptability and the ability to pivot in the face of challenges. The conversation also touches on the differences in investment environments across regions and the importance of a strong team over a perfect product.00:00 Introduction and Background01:50 Navigating the Science and Business Divide05:46 The Role of Angel Investors09:51 Teaching Entrepreneurship13:38 Trust and Team Dynamics in Startups17:38 Investment Strategies and Risk Management21:14 Regional Differences in Medical Investment23:02 International Consulting and Global Perspectives25:32 Cultural Insights from Global Experiences26:59 The Shark Tank Experience: Reality vs. TV29:21 The Rigorous Selection Process for Entrepreneurs31:33 Challenges in Startup Growth and Team Dynamics33:14 Funding Roadblocks and Cultural Differences37:11 Success Stories: From Struggles to Triumphs40:53 The Future of Investment: Incubators and Mentorship44:13 The Importance of Character in Entrepreneurship46:25 Investor Perspectives on Entrepreneurial SuccessGuest Information:Guest's Name: Dr. Kevin ScanlonGuest's Title/Position: Founder & CEO of International BioScience Guest's Linkedin: https://www.linkedin.com/in/kjscanlon/Company/Affiliation: Pasadena Angels https://www.linkedin.com/company/pasadena-angels/Guest's Bio: Dr. Kevin Scanlon is a seasoned leader in life sciences, with a career spanning academic medicine, executive roles in biotech and pharma, and active angel investing. Recognized by LA Techweek for his impact on the Los Angeles tech and business landscape, he served as Chairman of the Pasadena Angels, where nearly 100 investors funded over 50 companies during his tenure.Dr. Scanlon has led four biotech companies as CEO, including Melanoma Diagnostics, acquired by Myriad Genetics. At Berlex-Schering AG, he oversaw global genomic and oncology programs across the US, Europe, and Asia.His academic credentials include being a Leukemia Society Scholar, recipient of the Paul Martini Medical Research Prize (Germany), and co-founding editor of Cancer Gene Therapy (Nature Publishing Group). He has served as President of the International Society of Cell and Gene Therapy and authored 139 peer-reviewed papers, nine medical books, and seven U.S. patents. Dr. Scanlon is also the author of The Hybrid Entrepreneur. TakeawaysCharacter is crucial for entrepreneurial success.Investors look for strong team dynamics.Mentorship can significantly impact startup growth.Understanding investor vocabulary is essential for entrepreneurs.Trust issues can hinder investor-entrepreneur relationships.A strong team can pivot and adapt to challenges.Financial strategy is often a weak point for entrepreneurs.Communication of complex ideas is vital for success.Cultural differences can create friction in teams.Success stories often come from perseverance and adaptability.

In this episode, Naomi Cosman, Global Head of Marketing and Investor Relations at Koning, discusses the revolutionary breast imaging technology offered by Koning. The conversation covers the importance of patient comfort, the challenges of industry resistance, and the need for early detection of breast cancer. Naomi shares insights on marketing strategies, the role of mobile units in increasing accessibility, and the ongoing challenges with insurance coverage. The episode emphasizes the significance of integrating marketing across departments and the passion behind working in healthcare startups.00:00 Introduction to Koning Health and Breast Imaging Innovation02:30 Revolutionizing Breast Imaging: The Koning Vera Breast CT05:47 The Importance of Early Detection and Patient Comfort10:20 Overcoming Industry Resistance and Adoption Challenges15:49 Mobile Units and Accessibility in Breast Imaging20:43 Marketing Strategies: Engaging Patients and Physicians25:57 Insurance Challenges and Cost of Exams30:22 The Startup Culture and Passion for Healthcare35:59 Balancing Technology and Human Connection in Marketing40:24 Conclusion and Call to Action for Breast Health AwarenessGuest Information:Guest's Name:  Naomi CosmanGuest's Title/Position: Global Head of Marketing & Investor RelationsGuest's Linkedin: https://www.linkedin.com/in/naomicosman/ Company/Affiliation: Koning Health https://www.koninghealth.com/Guest's Bio: Naomi Cosman is the Global Head of Marketing at Koning, where she leads the company’s overall marketing strategy, including PR, social media, creative, web, and campaign execution. With a double major in Communications and French from the University of Wisconsin-Madison, Naomi also holds marketing and business certificates from NYU and Harvard Business School. She brings over a decade of experience—five years at a Fortune 500 company in branding and campaign management, followed by five years with startups across various sectors. At Koning, Naomi partners with leadership to elevate brand awareness and public engagement, helping position the company as a leader in revolutionary women’s healthcare.

In this episode, Dr. Axa Yox shares her journey from biotechnology to nutrition, revealing how a deeper understanding of biochemistry, diet, and environment can unlock better health and longevity. She opens up about personal setbacks, the challenges of building a brand in the wellness space, and the critical role of educating people on the science behind nutrition. From insulin regulation to intermittent fasting and mindful eating, Axa offers practical insights to help listeners make empowered, informed decisions about their health.Chapters:00:00 Introduction to Dr. Oksa Jox02:11 Journey from Biotechnology to Nutrition04:30 Learning from Failures08:20 The Importance of Market Understanding10:07 Building a Personal Brand18:22 Explaining the Mechanisms of Healthy Eating26:32 The Role of Environment in Health30:03 Understanding Insulin and Glucose Metabolism32:56 The Importance of Intermittent Fasting36:05 Personal Health Transformations Through Diet39:02 The Misconceptions of Food Labels41:54 Building a Personal Brand in Health46:06 Future Aspirations and Growth in Health Coaching48:02 Stress Management and Breathing Techniques52:11 The Concept of Promises and Personal GrowthGuest Information:Guest's Name: Dr. Axa YoxGuest's Title/Position: Fouder & Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/dr-axa-yox/Company/Affiliation: X Theory Inc https://x-theory.kit.com/1e03b15cdcGuest's Bio: Dr. Axa Yox is a former scientist turned transformational speaker, author, and LinkedIn strategist. With a PhD in Microbiology and Genetics and a career marked by international fellowships and groundbreaking research, she has authored over 45 scientific papers and holds 12 inventions. Now based in Miami, she’s the founder of X Theory, host of the W.H.Y. – What How Y podcast, and author of Foolfilled Life, a motivational guide to rewiring the brain to overcome anxiety and procrastination. A TEDx 2025 speaker-in-prep and executive contributor at BRAINZ Magazine, Axa brings deep scientific insight to personal development, branding, and the psychology of change.